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What Are Small Regulatory RNAs?
An increasing number of RNAs have been recently shown to
possess regulatory functions similar to those of proteins. In
bacteria, these regulatory RNAs are usually noncoding and are
short size (50–500 nts) transcripts that are often referred to as
small RNAs (sRNAs) [1,2]. These sRNAs are synthesized under
specific environmental conditions and play a major role in the
regulation of various cellular processes (Figure 1) [3]. Most of
them act via an imperfect antisense base-pairing with their target
mRNAs. Duplex formation usually results in inhibition or
stimulation of mRNA target translation. In some cases, sRNAs
can also bind proteins to influence their activities (e.g., 6S RNA).
Compared to protein-dependent mechanisms, sRNAs require less
energy, act faster and also allow a coordinated regulation of
several targets. Owing to these characteristics, sRNAs allow
efficient adaptation of bacteria to their ever-changing environ-
ment. Therefore, the possibility exists that some sRNAs may be
involved in antibiotic resistance. In this report, we provide
evidence that illustrates the growing number of sRNAs that
influence bacterial resistance to antibiotics.
Is There a Link between Antibiotic Exposure and
sRNAs Expression in Bacteria?
In the last few years, several studies have shown a correlation
between bacterial sRNA expression and antibiotic exposure. An
initial study identified four sRNAs in Salmonella Typhimurium
with an enhanced expression when the bacterium was challenged
with antibiotics such as tigecycline or tetracycline [4], both of
which inhibit bacterial protein synthesis. Remarkably, deletion of
one of these sRNA genes that encodes SroA reduced Salmonella
Typhimurium viability when exposed to tigecycline. Therefore,
SroA sRNA activation in a strain exposed to tigecycline may
influence bacterial resistance to that antibiotic. In an additional
study using the Staphylococcus aureus strain as a model, the
expression of some sRNAs correlated with exposure to four
antibiotics (vancomycin, linezolid, ceftobiprole, and tigecycline)
[5]. These recent data that suggest functional links between sRNA
expression and the presence of antibiotics raise the important
question whether sRNAs play a role in antibiotic resistance.
How Can sRNA Functions Lead to Altered
Antibiotic Resistance?
Mechanisms of antibiotic resistance
Antibiotics can use miscellaneous mechanisms of action to
target vital processes such as nucleic acid and protein synthesis, as
well as envelope integrity. Strikingly, various bacterial sRNAs are
involved in these functions (Figure 1) [3]. As a consequence,
perturbation of sRNA activity may lead to alteration of cellular
processes, and a potential outcome is modulation of bacterial
antibiotic resistance.
sRNAs involved in RNA synthesis
Some antibiotics alter the transcriptional machinery, and
sRNAs have been found to modulate this process. For instance,
the 6S RNA functions through interaction with housekeeping
forms of RNA polymerase holoenzyme in gram-negative and
gram-positive bacteria. Even if 6S sRNA has not been shown to
directly affect antibiotic resistance by regulating transcription, cells
lacking 6S RNA are defective for persistence [6]. Since persistence
is a process that makes bacteria highly tolerant to different
antibiotics, data suggest a functional link between 6S RNA
expression and antibiotic sensitivity.
sRNAs involved in protein synthesis
Protein synthesis involves translation of an mRNA. Many
antibiotics interfere with protein synthesis, targeting various steps
of the translation process [7]. Ribosomes stalled by protein
synthesis inhibitors (e.g., chloramphenicol) can be rescued by a
quality-control mechanism that involves the transfer-messenger
RNA (tmRNA). However, cells lacking tmRNA are more sensitive
to these inhibitors due to the defects in mRNA and protein quality
monitoring [8]. In addition, mutations in tmRNA decrease
persister cell survival, thus increasing susceptibility to a variety of
antibiotics.
sRNAs involved in cell membrane integrity
Many antibiotics have to penetrate the bacterial cell envelope to
be effective. For instance, the outer membrane of gram-negative
bacteria functions as a selective barrier by combining a
hydrophobic lipid bilayer with pore-forming proteins (porins).
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Therefore, any factor influencing bacterial membrane synthesis or
permeability could lead to antibiotic resistance. There are two cell-
penetrating pathways that can be used by antibiotics: the lipid-
mediated pathway for macrolides (e.g., erythromycin) and other
hydrophobic antibiotics, and the general diffusion porins for
hydrophilic antibiotics (e.g., the family of b-lactams, gentamycin,
and kanamycin) [9].
Lipopolysaccharides (LPS) are components of the outer
membrane of gram-negative bacteria and provide a barrier
against antibiotics using the lipid-mediated pathway [9]. The
PhoP/PhoQ two-component system can activate many genes
involved in LPS modifications and, by extent, can control
resistance to antibiotics [10]. Interestingly, two sRNAs (MicA
and GcvB) have been described as regulators of phoPQ mRNA in
Escherichia coli [11]. Moreover, another sRNA, ArcZ, has been
shown to directly regulate the expression of a phosphoethanola-
mine transferase, also involved in LPS modifications [12].
Alteration of outer membrane composition, particularly outer
membrane proteins (Omp), represents one of the major mechanisms
for antibiotic resistance. Thus, sRNAs such as MicF orMicC, which
target the major porins OmpF and OmpC respectively, are likely to
mediate antibiotic resistance. Moreover, at least six other sRNAs
(InvR, MicA, OmrA/B, RseX, and RybB) have already been
described as regulator of Omps [13], thus modulating outer
membrane fluidity and permeability in gram-negative bacteria.
sRNAs involved in the regulation of membrane
transporters
The active pumping of antibiotics out of the cells by efflux pump
systems also contributes to antibiotic resistance [14]. As an
example, the MtrCDE efflux pump and the inner membrane
protein MtrF allow Neisseria gonorrhoea to resist various
hydrophobic antimicrobials, including penicillin and erythromy-
cin. Interestingly, NrrF sRNA reduces mtrF mRNA levels and
therefore inhibits MtrF production [15].
One additional example is the overexpression of DsrA sRNA,
which was found to induce multidrug resistance in E. coli [16]. In
fact, through its positive control of the alternative sigma factor sS
(or RpoS), DsrA triggers the expression of genes encoding the
MdtEF multidrug efflux pump and thus affects antibiotic
susceptibility. Since other sRNAs (ArcZ, RprA, and OxyS) are
involved in rpoS regulation [17], these additional regulators can
play a role in the control of the MdtEF efflux pump.
Similarly, the sRNA RyhB activates the translation of cirA
mRNA that encodes a receptor and translocator of the antibiotic
colicin Ia [18–20]. Under normal growth conditions, the Shine-
Dalgarno (SD) sequence of cirA mRNA is not accessible for
translation initiation. However, under iron starvation conditions,
RyhB sRNA is expressed and pairs with cirA and that allows the
accessibility to the SD sequence [18]. Consequently, the higher
number of CirA transporter produced confers an increased
Figure 1. Functional connections between antibiotics’ modes of action and regulatory RNAs. sRNAs modulate protein activity or
influence target mRNAs fate. Some of those sRNA targets are part of cellular processes that can be affected by antibiotics. Accumulating evidence
suggests that several sRNAs alter antibiotic resistance by modulating bacterial cell wall (SprX), cell membrane (RybB), transcription (6S RNA), and
translation (tmRNA).
doi:10.1371/journal.ppat.1004299.g001
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sensitivity to colicin Ia. These results support the interpretation
that RyhB modulates the sensitivity to colicin Ia through CirA.
sRNAs involved in cell wall turnover
Microbial cell wall is an essential structural component that is
responsible for reproductive division and for maintaining cellular
integrity. Furthermore, the cell wall limits entry of potentially
harmful macromolecules into the cell. In a large scale analysis of S.
aureus, it was observed that a sRNA was down-regulated when
cells were challenged with vancomycin and ceftobiprole, two
antibiotics that target the cell wall [5]. Remarkably, this down-
regulated sRNA was antisense to the mecA gene encoding the
penicillin-binding protein 2a (PBP2a) which induces a higher level
of resistance to b-lactams. This observation suggests a putative role
of this sRNA in antibiotic resistance. Recently, another S. aureus
sRNA, SprX (also known as RsaOR), was shown to inhibit SpoVG
protein synthesis, a protein encoded by the yabJ-spoVG operon
involved in glycopeptide and oxacillin resistance [21].
Could sRNAs Be Used as Working Models to
Design New Antibiotics?
RNAs represent an unexploited area of potential molecules for
antibacterial design. The recent discovery of sRNAs as a general
class of powerful regulators has revolutionized our understanding
of gene regulation. sRNAs are involved in many cellular processes
in response to stress or when cells are challenged with antibiotics.
Unraveling the functions of sRNAs in virulence and host immunity
will provide fundamental knowledge that can be used to develop
next-generation antibiotics using sRNAs as original targets.
However, many unanswered questions remain with respect to
RNA biology, but we are convinced that sRNA-based therapeutic
treatment of infectious diseases may become useful tools in the
near future.
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